Furthermore, WT1 also exhibits oncogenic activity, and its overexpression has been well demonstrated in ovarian cancer; thus, WT1 immunohistochemical detection is considered as a diagnostic marker of ovarian cancer (Figure 2B) (8). This evidence concerns the gene WT1 and ovarian carcinoma.